Daily Anesthesiology Research Analysis
Three perioperative studies stand out today: a randomized trial shows continuous norepinephrine infusion stabilizes blood pressure during induction in high-risk noncardiac surgery; a randomized adult trial delineates distinct complication profiles for deep versus awake extubation; and a systematic review/meta-analysis finds the Hypotension Prediction Index accurately predicts hypotension but with uncertain clinical benefit over MAP-based care.
Summary
Three perioperative studies stand out today: a randomized trial shows continuous norepinephrine infusion stabilizes blood pressure during induction in high-risk noncardiac surgery; a randomized adult trial delineates distinct complication profiles for deep versus awake extubation; and a systematic review/meta-analysis finds the Hypotension Prediction Index accurately predicts hypotension but with uncertain clinical benefit over MAP-based care.
Research Themes
- Hemodynamic management during anesthetic induction
- Extubation strategies and airway safety
- AI/ML-based intraoperative hypotension prediction
Selected Articles
1. Continuous versus bolus norepinephrine administration and arterial blood pressure stability during induction of general anaesthesia in high-risk noncardiac surgery patients: a randomised trial.
In a single-centre randomized trial of 72 high-risk noncardiac surgery patients, continuous norepinephrine infusion during induction reduced mean arterial pressure variability versus repeated boluses. Continuous arterial catheter monitoring and a quantitative variability metric (gARV) supported the primary endpoint. No hard organ outcomes were reported, but hemodynamic stability improved.
Impact: Induction hypotension is frequent and linked to organ injury; a practical, immediately implementable intervention improved blood pressure stability in high-risk patients.
Clinical Implications: Consider protocolized continuous norepinephrine infusions during induction for high-risk patients to attenuate MAP variability, with arterial line monitoring and infusion pump availability. Integrate into hemodynamic bundles alongside adequate preload, vasopressor timing, and anesthetic dosing.
Key Findings
- Continuous norepinephrine infusion during induction improved blood pressure stability versus repeated manual boluses, measured by lower gARV of MAP within 15 minutes.
- Arterial catheter continuous monitoring enabled precise assessment of the primary endpoint.
- Randomized allocation of 72 patients (71 analyzed) demonstrated feasibility and safety of a continuous vasopressor strategy.
Methodological Strengths
- Randomized allocation with continuous arterial pressure monitoring
- Objective, quantitative primary endpoint (gARV of MAP) in a prespecified time window
Limitations
- Single-centre design with modest sample size limits generalizability
- Short observation window and lack of organ injury endpoints (e.g., AKI, myocardial injury)
Future Directions: Multicentre trials powered for clinical outcomes (AKI, myocardial injury) and protocolized induction bundles comparing vasopressor strategies and dosing algorithms are warranted.
BACKGROUND: Hypotension after induction of general anaesthesia is common in high-risk patients having noncardiac surgery. Anaesthesiologists often give manual boluses of vasopressors repeatedly to maintain blood pressure during induction of general anaesthesia, including the fast-acting vasopressor norepinephrine which has a short half-life. We tested the hypothesis that giving norepinephrine continuously during induction of general anaesthesia, compared with giving it as repeated manual boluses, improves blood pressure stability in high-risk noncardiac surgery patients. METHODS: In this single-centre trial, 72 participants undergoing noncardiac surgery were randomised to continuous norepinephrine infusion or manual bolus norepinephrine administration during induction of general anaesthesia. Blood pressure was monitored continuously with an arterial catheter. The primary endpoint was blood pressure stability, quantified as the generalised average real variability of mean arterial pressure within 15 min after starting induction of general anaesthesia. RESULTS: A total of 71 participants completed the study (mean [range] age: 66 [47-86] y; 48% female). The mean (standard deviation) generalised average real variability of mean arterial pressure was 19 (6) mm Hg min CONCLUSIONS: Giving norepinephrine continuously during induction of general anaesthesia, compared with giving it as repeated manual boluses, improved blood pressure stability in higher-risk individuals undergoing noncardiac surgery. CLINICAL TRIAL REGISTRATION: NCT05997303.
2. A comparison of deep versus awake tracheal extubation in adults: a randomized controlled trial.
This 220-patient RCT found that awake extubation increased pre-extubation cough and hypoxemia but reduced post-extubation airway obstruction and apnea compared with deep extubation. Neither technique was conclusively safer overall, highlighting the need to tailor extubation strategies to patient risk and provider context.
Impact: Extubation is a universal, high-stakes step. Clear, head-to-head adult RCT data defining trade-offs between deep and awake techniques fills a key evidence gap.
Clinical Implications: Select extubation technique based on risk profile: awake extubation may lower post-extubation obstruction/apnea risk but increases cough; deep extubation may minimize pre-extubation coughing and hypoxemia but requires vigilance for airway obstruction post-extubation. Prepare tailored airway interventions accordingly.
Key Findings
- Awake extubation increased pre-extubation airway/respiratory complications (RR 5.1; 95% CI 2.8–9.5; p<.001), driven by cough (RR 6.8) and hypoxemia (RR 3.6).
- After extubation, awake extubation reduced composite complications (RR 0.7; p=.028), airway obstruction (RR 0.2; p<.001), and apnea (RR 0.3; p=.025), but increased cough (RR 2.9).
- No serious adverse events occurred; fewer post-extubation airway interventions were needed with awake extubation (RR 0.2; p<.001).
Methodological Strengths
- Prospective randomized design with standardized anesthetic regimen
- Comprehensive outcome set including pre- and post-extubation complications and airway interventions
Limitations
- Retrospective trial registration may introduce bias concerns
- Conducted in favorable airways and elective settings, limiting generalizability to high-risk airways
Future Directions: Evaluate stratified strategies in high-risk airway populations and assess patient-centered outcomes (PACU events, ICU admissions) and cost-effectiveness.
BACKGROUND: Awake extubation is deemed a generally safe option for tracheal extubation in low-risk patients, while anesthetized, or"deep" extubation is often considered best suited to seasoned providers due to its perceived hazards. However, inadequate data exists about the relative safety of deep and awake extubations in the adult population. METHODS: Adult patients (n=220) with favorable airways undergoing elective surgeries under general tracheal anesthesia were enrolled prospectively. Following a standardized volatile anesthetic regimen, patients were randomized to undergo deep or awake tracheal extubation. The primary outcome was the occurrence of at least one airway or respiratory complication. Secondary outcomes included airway interventions, hemodynamic parameters, severe emergence agitation, and sore throat severity. RESULTS: Pre-extubation, awake extubations exhibited an increased rate of any airway and respiratory complications (risk ratio [RR] - 5.1; 95% confidence interval [CI] - 2.8-9.5; p<.001), attributable to greater incidences of cough (RR - 6.8; 95% CI - 3.2-14.3, p>.001) and hypoxemia (RR - 3.6; 95% CI - 1.3-10.6, p=.010). After extubation, a significantly decreased rate of one or more complications occurred in the awake extubation group (RR - 0.7; 95% CI - 0.6-1.0; p=.028). Awake extubations were associated with fewer incidences of airway obstruction (RR - 0.2; 95% CI - 0.1-0.4, p<.001) and apnea (RR - 0.3; 95% CI - 0.1-0.9; p=.025), but higher rates of any severity cough (RR - 2.9; 95% CI - 1.6-5.2; p<.001). Awake extubations required significantly fewer airway interventions after extubation (RR - 0.2; 95% CI - 0.1-0.6; p<.001). No serious adverse events occurred. CONCLUSIONS: Deep and awake extubations produce distinct airway and respiratory complication profiles, without either being conclusively safer. The risks posed by each technique during emergence and after extubation should be considered by anesthesia providers when formulating an extubation strategy. TRIAL REGISTRATION: This study was retrospectively registered at clinicaltrials.gov (NCT05361850) on April 23, 2022.
3. Intraoperative hypotension prediction in cardiac and noncardiac procedures: is HPI truly worthwhile? A systematic review and meta-analysis.
Across 22 studies, HPI achieved sensitivity and specificity of 83% (AUC 0.90) for predicting IOH and reduced time-weighted hypotension when combined with invasive monitoring. However, benefits varied by surgical context (weaker in cardiac), and superiority over MAP-based strategies for clinical outcomes remains unproven.
Impact: Guides adoption of ML-based hypotension prediction by highlighting strong diagnostic performance but uncertain outcome benefits, informing resource allocation and protocol design.
Clinical Implications: If used, HPI should be embedded in bundles emphasizing MAP targets, staff training, and timely vasopressor/fluids, with clear thresholds and response protocols; routine use solely for outcome improvement is premature.
Key Findings
- Pooled diagnostic performance: sensitivity 83%, specificity 83%, AUC 0.90 for predicting IOH.
- HPI plus invasive arterial monitoring reduced the time-weighted average of hypotension compared with standard methods.
- Diagnostic and preventive effects were weaker in cardiac surgery; improvements did not clearly translate to better organ outcomes.
Methodological Strengths
- Comprehensive multi-database search with random-effects meta-analysis
- Subgroup analyses by surgical type (cardiac vs non-cardiac) and evaluation of TWA hypotension
Limitations
- Heterogeneity of included studies and potential device/vendor bias
- Outcome data on organ injury and mortality were limited and inconsistent
Future Directions: Independent, pragmatic trials should test HPI-driven protocols versus MAP-targeted care on kidney/cardiac outcomes and cost-effectiveness across surgical populations.
BACKGROUND: Intraoperative hypotension (IOH), defined as a mean arterial pressure (MAP) below 65 mmHg, is a common complication during surgery and is associated with significant postoperative morbidity, including acute kidney injury, myocardial injury, stroke, and increased mortality. Despite the availability of traditional monitoring techniques, predicting and preventing IOH remains a challenge. The Hypotension Prediction Index (HPI), a machine-learning algorithm developed by Edwards Lifesciences, aims to predict IOH by analyzing real-time arterial waveform data, offering an opportunity for proactive management. OBJECTIVE: This systematic review and meta-analysis evaluate the efficacy of the HPI in predicting and preventing IOH in cardiac and non-cardiac surgeries compared to standard blood pressure monitoring techniques. METHODS: A comprehensive search was conducted in PubMed, Scopus, Embase, and Web of Science databases for studies published from January 2019 to May 2024. Studies were included if they utilized machine learning algorithms, including HPI, to predict or detect IOH in adult surgical patients. Sensitivity, specificity, area under the curve (AUC), and time-weighted average (TWA) of hypotension were the primary outcomes. Subgroup analyses were performed to evaluate differences between cardiac and non-cardiac surgeries. Meta-analytic methods were applied using random-effects models to account for study variability. RESULTS: A total of 22 studies were included, encompassing both cardiac and non-cardiac procedures. The HPI demonstrated an overall sensitivity of 83% and specificity of 83% in predicting IOH. The pooled AUC for all surgeries was 0.90. However, subgroup analysis revealed variability in HPI performance between cardiac and non-cardiac surgeries, with lower diagnostic odds ratios (DOR) in cardiac settings. HPI combined with invasive arterial blood pressure monitoring reduced the TWA of hypotension more effectively than either invasive or non-invasive methods alone. The comparison of HPI and MAP for diagnostic accuracy showed minimal differences across all time frames, with SMD values close to zero. CONCLUSION: Our study shows that the HPI has high sensitivity and specificity in predicting intraoperative hypotension, but its clinical advantage over standard MAP-based monitoring is uncertain. While HPI reduces hypotension duration, this may not improve cardiovascular or renal outcomes. Further independent trials are needed to validate its effectiveness before widespread adoption, and it should be considered alongside simpler interventions like staff education and MAP targeting in the meantime.